title: Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: going beyond associations.
authors.affiliation: Mayo Clinic, Rochester, MN 55905, USA. ingle.james@mayo.edu
authors.forename: James N
authors.initials: JN
authors.lastname: Ingle
mesh_terms: D000077384:Anastrozole; D000730:Androstadienes / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016022:Case-Control Studies; D005260:Female; D015870:Gene Expression; D055106:Genome-Wide Association Study; D006801:Humans; D020381:Interleukin-17 / Q000235:genetics; D015810:Linkage Disequilibrium; D009140:Musculoskeletal Diseases / Q000139:chemically induced*; D009570:Nitriles / Q000009:adverse effects / Q000627:therapeutic use; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide; D014230:Triazoles / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000730:Androstadienes; D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; D020381:Interleukin-17; D009570:Nitriles; D014230:Triazoles; D000077384:Anastrozole; C056516:exemestane